Which marker is included in the general neuroendocrine IHC panel along with chromogranin and synaptophysin?

Prepare for the CMID Test. Study with flashcards and multiple choice questions, each question contains hints and explanations. Get ready for your exam with confidence!

Multiple Choice

Which marker is included in the general neuroendocrine IHC panel along with chromogranin and synaptophysin?

Explanation:
The main idea here is how neuroendocrine tumors are profiled with immunohistochemistry. Chromogranin A and synaptophysin are classic markers that confirm neuroendocrine differentiation by highlighting neuroendocrine granules and cell membranes, respectively. A common additional marker in this context is S-100, which is used to identify sustentacular cells that surround tumor nests in paragangliomas and pheochromocytomas. The presence of these S-100–positive sustentacular cells around chromogranin/synaptophysin–positive nests supports a paraganglioma/pheochromocytoma diagnosis and helps distinguish these tumors from other non-paraganglionic neuroendocrine neoplasms. Melan-A is a melanocytic marker, not part of the neuroendocrine panel. FOXL2 is a marker relevant to granulosa cell tumors, not neuroendocrine tumors. CD10 has various uses but does not serve the same diagnostic role in standard neuroendocrine panels as S-100 does for identifying sustentacular cells in paragangliomas.

The main idea here is how neuroendocrine tumors are profiled with immunohistochemistry. Chromogranin A and synaptophysin are classic markers that confirm neuroendocrine differentiation by highlighting neuroendocrine granules and cell membranes, respectively. A common additional marker in this context is S-100, which is used to identify sustentacular cells that surround tumor nests in paragangliomas and pheochromocytomas. The presence of these S-100–positive sustentacular cells around chromogranin/synaptophysin–positive nests supports a paraganglioma/pheochromocytoma diagnosis and helps distinguish these tumors from other non-paraganglionic neuroendocrine neoplasms.

Melan-A is a melanocytic marker, not part of the neuroendocrine panel. FOXL2 is a marker relevant to granulosa cell tumors, not neuroendocrine tumors. CD10 has various uses but does not serve the same diagnostic role in standard neuroendocrine panels as S-100 does for identifying sustentacular cells in paragangliomas.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy